当前位置:
X-MOL 学术
›
Neuropsychopharmacology
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Correction: Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials.
Neuropsychopharmacology ( IF 6.6 ) Pub Date : 2020-04-01 , DOI: 10.1038/s41386-019-0598-y Hideaki Tani 1, 2 , Shotaro Takasu 1, 3 , Hiroyuki Uchida 1, 4 , Takefumi Suzuki 5 , Masaru Mimura 1 , Hiroyoshi Takeuchi 1, 6
Neuropsychopharmacology ( IF 6.6 ) Pub Date : 2020-04-01 , DOI: 10.1038/s41386-019-0598-y Hideaki Tani 1, 2 , Shotaro Takasu 1, 3 , Hiroyuki Uchida 1, 4 , Takefumi Suzuki 5 , Masaru Mimura 1 , Hiroyoshi Takeuchi 1, 6
Affiliation
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
中文翻译:
校正:与精神分裂症成功减少抗精神病药剂量有关的因素:前瞻性临床试验的系统评价和随机对照试验的荟萃分析。
该文件的修订版已经发布,可以通过文件顶部的链接进行访问。
更新日期:2020-01-23
中文翻译:
校正:与精神分裂症成功减少抗精神病药剂量有关的因素:前瞻性临床试验的系统评价和随机对照试验的荟萃分析。
该文件的修订版已经发布,可以通过文件顶部的链接进行访问。